Rai, Kunal
- UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #14,296
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$766.4K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#14,296
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Rai, Kunal as a PI. Multi-PI records show the full award amount for context.
- 5R01CA245395-04R01Contact PIUCHL5 as a regulator and therapeutic target in metastatic melanomaUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$403.2Kaward amount
- 5R01CA226269-04R01Contact PIRole of UBR7, a novel H2BK120 E3 ubiquitin ligase, in suppression of breast cancerUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$363.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Rai, Kunal as a PI.
FY2023 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardUT MD Anderson Cancer Center
- 2015$500K Cumulative Funding
- 2016R01 Grant Holder
- 2017$1M Cumulative Funding
- 2019$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #4936
- 2021Entered Top 25% NationallyRanked #4936
- 2023$5M Cumulative Funding